The Multifaceted Benefits of Probiotics and Postbiotics: Unlocking Gut-Brain, Immune, and Metabolic Health

Introduction

Overview of Human Microbiome

The human microbiome represents a complex and profoundly influential inner ecosystem, consisting of trillions of microorganisms such as bacteria, fungi, viruses, and other microbes. These microorganisms play a critical role in digestion, metabolism, immunity, metabolism, and mental health (Turnbaugh et al., 2007; Suez et al., 2019). They contribute to numerous physiological processes, including:

• Breaking down fibers and complex carbohydrates
• Immune system modulation
• Synthesis of nutrients such as B12 and K2
• Protecting against harmful bacteria
• Mood regulation and supporting the gut-brain axis (Ouwehand et al., 2002; Plaza-Diaz et al., 2019)

Disruptions to this delicate microbial balance- caused by antibiotics, stress, poor diet, antibiotics, or disease states- can lead to gut dysbiosis, which is linked to chronic inflammation, autoimmune condition, allergies, metabolic disorders, and mood disturbances (Sanders et al., 2018).

Modulating the microbiome ecosystem can be accomplished through targeted interventions, such as with prebiotics, probiotics, and postbiotics- which stand out as distinct yet interconnected strategies (Plaza-Diaz et al., 2019).

 

Roles of Prebiotics, Probiotics, and Postbiotics in Human Health

Prebiotics

Prebiotics act as “fuel,” or specialized nourishment for beneficial microbes in the microbiome. They usually consist of non-digestible food components (such as fibers like resistant starch, inulin, fructooligosaccharides, and galactooligosaccharides) which selectively stimulate the growth and activity of beneficial gut bacteria strains (Gill et al., 2001). By nourishing beneficial probiotic strains, prebiotics can help with:

• Enhancing microbial diversity
• Promoting the production of short-chain fatty acids (such as butyrate)
• Immune regulation
• Improving nutrient absorption
• Improving bowel regularity

Probiotics

Probiotics are live beneficial microorganisms and confer health benefits on the host when administered in the proper amounts. Some examples of common probiotic strains include Lactobacillus and Bifidobacteriumstrains, as well as beneficial yeasts such as Saccharomyces boulardii. Probiotics can help restore balance to the gut microbiome, strengthen the gut lining, and outcompete against harmful pathogens. Clinical research has shown that probiotic intake can provide other health benefits, including:

Digestive Health Benefits

• • Lactobacillus acidophilus DDS-1: Clinically shown to reduce gastrointestinal discomfort related to travel and lactose intolerance (Ouwehand et al., 2002). Additionally, it has demonstrated an ability to regulate bowel habits and improve stool consistency.
  • Bifidobacterium animalis subsp. lactis HN019: Demonstrated to significantly increase the frequency of bowel movements in patients experiencing fewer than three per week (Ibarra et al., 2018).
  • Lactobacillus plantarum Lp-115: Aids in digestion, reduces bloating, and enhances gut microbiota diversity (Gomes et al., 2020).
  • Lactococcus lactis LL-23: Contributes to microbial diversity and supports gut barrier integrity (Gomes et al., 2020).

 

Enhancing Immune Response and Reduces the Severity and Duration of Certain Infections

• • Bifidobacterium animalis subsp. lactis HN019: In a clinical trial with adults aged 70 and older, HN019 was shown to increase helper T lymphocytes and natural killer (NK) cell activity in individuals with low immune response (Gill et al., 2001).
  • Lactobacillus acidophilus La-14 and Bifidobacterium animalis subsp. lactis BL-04: In a clinical trial comparing various probiotic strains on immune responses, both strains significantly increased serum IgG levels compared to controls (Paineau et al., 2008).
  • Bifidobacterium animalis subsp. lactis BL-04: In a randomized, double-blind, placebo-controlled trial, this strain was shown to reduce the incidence of respiratory tract infections and viral shedding during a rhinovirus infection, with continued supplementation for 28 days. In another trial with 465 healthy adults, BL-04 (at a dose of 2 billion CFU) outperformed both placebo and a multi-strain probiotic in reducing respiratory tract infection incidence (19% reduction vs. 27% with multi-strain) (Turner et al., 2017; Wang et al., 2018;    West NP et al., 2014).
  • Lactobacillus rhamnosus GG (LGG): One of the most extensively studied probiotic strains, LGG offers benefits for immune, digestive, and cognitive health.
    • Clinical studies have shown LGG reduces the risk of upper respiratory tract infections, rhinovirus-related symptoms, acute otitis media, and antibiotic use during viral infections (Liu et al., 2013; Davidson et al., 2011).
    • In hospitalized children (India and Poland), LGG significantly reduced hospital stay, frequency and duration of diarrhea, and IV therapy needs. It also improved GI function and increased IgG in rotavirus-associated diarrhea (Basu et al., 2009; Czerwionka-Szaflarska et al., 2009; Pieścik-Lech et al., 2012; Sindhu KN, et al., 2014).
    • In ulcerative colitis patients, LGG was as effective as mesalazine in reducing relapse rates over a 6-month period and showed a better adverse event profile and longer relapse-free periods (Zocco et al., 2006).
    • In a long-term trial from infancy to age 13, LGG supplementation significantly reduced the risk of ADHD and Asperger’s syndrome (Pärtty et al., 2015).
    • In two trials beginning in the second trimester of pregnancy, LGG reduced the severity of maternal allergic disease. Continued supplementation through breastfeeding reduced the risk of atopic dermatitis in infants, with lasting benefits through early childhood (Rautava et al., 2002; Ou et al., 2012; Kalliomäki et al., 2007).
  • Bifidobacterium bifidum BB-06: Strengthens intestinal immunity and helps protect against infections (Simon et al., 2021).
  • Lactobacillus paracasei LPC-37: Reduces inflammation and supports healthy immune function (Simon et al., 2021).

Metabolic Benefits

• • In a randomized, double-blind, placebo-controlled trial involving 32 overweight and obese women, a probiotic mixture (containing Lactobacillus acidophilus LA-14, Lactobacillus casei LC-11, Lactococcus lactis LL-23, Bifidobacterium bifidum BB-06, and Bifidobacterium lactis BL-4) was significantly associated with improvements in a range of metabolic markers (Gomes et al., 2020). These included:
    • Healthier BMI, weight, fat mass, and lean mass
    • Improved conicity index (a measure of fat distribution)
    • Increased protein and monounsaturated fat intake
    • Reduced levels of glycated hemoglobin (HbA1c), TNF-α, and the IL-6/IL-10 ratio
  • Bifidobacteria strains have also shown specific cholesterol-absorbing properties, contributing to reductions in both total serum cholesterol and LDL-C levels (Bordoni et al., 2013).

 

Supports Mental Well-Being, Neurological and Cognitive Function

• • Lactobacillus and Bifidobacterium strains support the gut-brain axis by influencing neurotransmitter production and strengthening gut barrier integrity.
  • Lactobacillus rhamnosus GG (LGG): Early-life supplementation with LGG has been clinically linked to a reduced risk of developing ADHD and Asperger’s syndrome, highlighting its potential cognitive benefits (Pärtty et al., 2015).
  • Lactobacillus and Bifidobacterium species have been shown to reduce neuroinflammatory markers and protect against neuroinflammation, supporting overall brain health and mental well-being (Plaza-Diaz et al., 2019).

 

Postbiotics – What Are They and Why Do They Matter?

While prebiotics and probiotics have long dominated the gastrointestinal landscape, postbiotics are emerging as the next-generation tool in microbiome health. Postbiotics are not living organisms but are the cellular components and beneficial metabolites produced by probiotic strains during the fermentation process- this helps to deliver targeted health benefits without the need for microbial survival or colonization. Postbiotics include a diverse array of bioactive compounds (Silva et al., 2018; Fu et al., 2021), including:

• Bacteriocins (natural antimicrobial peptides)
• Exopolysaccharides
• Peptidoglycans and cell wall fragments
• Short-chain fatty acids (e.g., butyrate, propionate, acetate)
• Heat-killed probiotic cell fractions
• Metabolites that interact with immune and nervous system receptors

 

Several unique strains have been found to produce a variety of postbiotics, including:

• Pediococcus acidilactici UL5: A robust organism capable of withstanding both the human gastric and small intestinal environments. This organism is unique due to its ability to produce a postbiotic bacteriocin called pediocin PA-1, an active antimicrobial against pathogenic Listeria species and does not exert detrimental effects on the ileal environment, as demonstrated in a gastrointestinal model (Proacticin Poster, 2020).
• Lactococcus lactis MJC18: Similar to Pediococcus acidilactici UL5, this is another probiotic organism capable of producing a potent postbiotic, Nisin Z. This bacteriocin is known for both its bactericidal and bacteriostatic actions against many gram-positive pathogens such as Listeria, Staphylococcus, Bacillus, and Clostridium. Nisin Z. When used in combination with methicillin, Nisin Z was shown to improve the efficacy of the antibiotic against methicillin-resistant Staphylococcus aureus when used topically for 3 hours on porcine skin. More recent studies have discovered that Nisin Z also exerts antiviral properties, especially in combination with antivirals (Ellis et al., 2019; Fu et al., 2021).
• Bifidobacterium animalis subsp. lactis BLC1: An organism used in functional foods and supplements for over a decade. BLC1 has demonstrated some anti-cancer properties in vitro when combined with pro-anthocyanidins in a simulated gastrointestinal model (Holkem et al., 2020; Bottacini et al., 2011).

 

Postbiotics have also been shown to impact health in a variety of ways, which include:

• Modulating the Immune System: Postbiotics interact directly with immune cells in the gut-associated lymphoid tissue, which can enhance mucosal immunity and help reduce chronic inflammation. In addition, peptidoglycans and lipoteichoic acids (found in postbiotic cell wall fragments) have shown to help stimulate Treg cell activity, which can promote immune tolerance and reduce allergy risk (Gill et al., 2001). One example of a strain that produces a postbiotic with immune-boosting effects is Bifidobacterium animalis subsp. lactis, which has been shown to enhance T-cell and natural killer cell activity in aging populations, leading to fewer infections.
• Supporting Digestion and Gut Barrier Integrity: Postbiotics support both mucin production and tight junction protein expression, which is critical in strengthening gut lining integrity and reducing leaky gut and associated inflammation. For example, butyrate, a key short-chain fatty acid postbiotic, has been shown in clinical studies to reduce symptoms of ulcerative colitis and irritable bowel syndrome by decreasing intestinal permeability and reducing proinflammatory cytokines like TNF-α and IL-6 (Plaza-Diaz et al., 2019).
• Mood and Neurotransmitter Regulation: Postbiotics play an important role in the gut-brain axis, influencing the production and regulation of key neurotransmitters such as dopamine, serotonin, and GABA (Sanders et al., 2018).
• Metabolic Health and Weight Management: Postbiotic SCFAs can reduce lipogenesis, enhance insulin sensitivity, and regulate appetite hormones like GLP-1 and leptin. For example, butyrate supplementation in both animals and humans has been associated with improved glycemic control, reduced hepatic fat accumulation, and lower fasting insulin levels (Gomes et al., 2020).
• Anti-Inflammatory and Antimicrobial Properties: Postbiotic preparations containing bacteriocins and organic acids can suppress pathogenic bacteria such as coli, Clostridium difficile, Listeria, and Salmonella, while also reducing intestinal inflammation. One example is the postbiotic-rich fermentation product from Pediococcus acidilactici UL5, which produces pediocin PA-1- an antimicrobial peptide effective against Listeria and C. difficile (Silva et al., 2018; Proacticin Poster, 2020).

 

Some of the other advantages of postbiotics include:

• Reliability: Does not rely on the ability to colonize the gut- health benefits are delivered regardless of microbiome constitution.
• Targeted effects: Specific metabolites can be chosen based on desired outcomes, such as antimicrobial properties or immunomodulation.
• Stability: Postbiotics resist stomach acid, do not require refrigeration, and maintain efficacy during shelf life (Suez et al., 2019).
• Safety: Can be utilized in vulnerable populations (e.g., elderly, infants, immunocompromised) where live microbes may pose a risk (Suez et al., 2019).

 

Importance of Broad-Spectrum Strain Diversity

Probiotic and postbiotic formulations that include a broad spectrum of strains offer a wider range of health benefits compared to single-strain or low-diversity products. Different probiotic strains have distinct mechanisms of action- some enhance digestive enzyme activity, others support the immune system, and some help with cognitive and neurological function. A diverse formulation increases the likelihood of targeting several physiological systems simultaneously, making it more effective for individuals with complex health needs or those looking for overall wellness support (Sanders et al., 2018). Microbial diversity also plays a key role in mimicking the natural diversity of the human gut microbiome. Modern lifestyles, stress, diet, and antibiotic use often reduce microbial diversity, which has been linked to various chronic diseases- including autoimmune disorders, obesity, and inflammatory bowel conditions (Sanders et al., 2018). Supplementing with a multi-strain probiotic helps reintroduce a wide array of beneficial bacteria, which can contribute to microbial resilience, outcompete harmful microbes, and support many metabolic functions. Clinical research suggests that high-diversity probiotics are associated with better outcomes in gastrointestinal-related disorders, allergy prevention, and immune support (Plaza-Diaz et al., 2019). Moreover, using multiple strains can help ensure that probiotic effects are consistent across a broader population.

 

Safety and Tolerability

Probiotics and postbiotics are generally well-tolerated in healthy adults, and when sourced from clinically studied strains, have a strong safety profile (Suez et al., 2019). The strains used in reputable supplements are usually derived from the human microbiome or food sources with a long history of safe consumption. Most human clinical trials report few to no adverse effects, even at high doses. When mild side effects do occur- such as temporary gas, bloating, or changes in stool consistency- they are usually short-lived and indicative of the body adjusting to a shift in gut microbiota composition. Postbiotics, since they are non-living microbial metabolites or cell fragments, offer an even greater safety margin (Simon et al., 2021). It is essential to select supplements that have undergone rigorous testing to confirm their safety at the dosages provided. Strain-specific research is especially important, as not all probiotics function the same or are appropriate for all populations. Clinically tested strains with published studies provide reassurance of both efficacy and safety, especially for long-term usage. Furthermore, high-quality products will provide clear labeling, transparency regarding strain identity and potency, and appropriate storage instructions. This allows consumers and practitioners to select products that align with both specific health concerns and general wellness goals, without compromising on tolerability.

 

Supporting Nutrients and Synergistic Compounds

To maximize the benefits of probiotic and postbiotic supplementation, it’s important to consider the inclusion of complementary nutrients that enhance their effectiveness. Incorporating prebiotics can serve as nourishment for probiotic bacteria, promoting their colonization and activity within the gut. Digestive enzymes can be especially helpful for individuals with enzyme deficiencies or compromised digestive function, ensuring that nutrients are properly broken down and absorbed- this can create a more favorable environment for probiotic action. Additionally, immune-supportive nutrients like zinc and vitamin D play a synergistic role by strengthening the immune response and enhancing the antimicrobial functions of the gut microbiota. Including these compounds in a supplement regimen not only supports the survival and performance of beneficial microbes but also contributes to a more comprehensive approach to digestive, immune, and overall wellness (Plaza-Diaz et al., 2019).

 

Conclusion

Postbiotics represent a paradigm shift in how we think about microbiome health. They are not just an alternative to probiotics—they are an evolution. Stable, safe, and mechanistically precise, postbiotics allow for predictable therapeutic outcomes in gut health, immunity, mood, and metabolism. When combined with prebiotics and broad-spectrum strains, they form a powerful trio that supports wellness from the inside out.

 

Jason Sailesh Dave, NMD, MS

Dr. Dave is a Medical Advisor for Restorative Formulations. He is licensed as a primary-care physician in the state of Washington who specializes in integrative medicine, functional medicine, and naturopathic medicine alongside conventional family medicine. After completing a hospital-based medical internship, he worked as an NIH postdoctoral clinical research fellow at the University of Virginia School of Medicine. Dr. Dave also served on the medical advisory board for several medical nutrition companies, where he was involved in researching and developing evidence-based supplements and medical nutrition products for healthcare practitioners. In addition, he is a medical writer and has lectured extensively to healthcare practitioners on the use of evidence-based nutritional supplements for conditions seen in everyday primary-care clinical practice.

 

References

Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol. 2009 Mar;43(3):208-13.

Bordoni A, Amaretti A, Leonardi A, et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Appl Microbiol Biotechnol. 2013;97(18):8273-8281.

Bottacini F, Dal Bello F, Turroni F, et al. Complete genome sequence of Bifidobacterium animalis subsp. lactis BLC1. J Bacteriol. 2011;193(22):6387-6388.

Czerwionka-Szaflarska M, Murawska S, Swincow G. Evaluation of influence of oral treatment with probiotic and/or oral rehydration solution on course of acute diarrhoea in children. Gastroenterology Review/Przegląd Gastroenterologiczny. 2009;4(3):166-172.

Davidson, Lisa E. et al. “Lactobacillus GG as an Immune Adjuvant for Live Attenuated Influenza Vaccine in Healthy Adults: A Randomized Double Blind Placebo Controlled Trial.” European journal of clinical nutrition 65 (2011): 501 – 507.

Ellis JC, Ross RP, Hill C. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria. Future Microbiol. 2019;14:1573-1587.

Fu, Y., Jaarsma, A.H. & Kuipers, O.P. Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs). Cell. Mol. Life Sci. 78, 3921–3940 (2021).

Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001;74(6):833-839.

Gomes AC, Hoffmann C, Mota JF. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera. Eur J Nutr. 2020;59(4):1751-1762.

Holkem AT, Favaro-Trindade CS, Lacroix M. Study of anticancer properties of proanthocyanidin-rich cinnamon extract in combination with Bifidobacterium animalis subsp. lactis BLC1 and resistance of these free and co-encapsulated materials under in vitro simulated gastrointestinal conditions. Food Res Int. 2020;134:109274.

https://secureservercdn.net/198.71.233.206/lp0.a27.myftpupload.com/wp-content/uploads/2020/06/proacticin-pa-syneova-poster.pdf

Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251.

Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(4):1019-1021.

Liu, S., Hu, P., Du, X. et al. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: A Meta-analysis of Randomized, Placebo-controlled Trials . Indian Pediatr 50, 377–381 (2013)

Ou CY, Kuo HC, Wang L, et al. Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2012;42(9):1386-1396.

Ouwehand, A. C., Salminen, S., & Isolauri, E. (2002). Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek, 82(1-4), 279-289.

Paineau D, Carcano D, Leyer G, et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008;53(1):107-113.

Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015 Jun;77(6):823-8.

Pieścik-Lech, Małgorzata et al. “Lactobacillus GG (LGG) and smectite versus LGG alone for acute gastroenteritis: a double-blind, randomized controlled trial.” European Journal of Pediatrics 172 (2012): 247 – 253.

Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019). Mechanisms of action of probiotics. Advances in Nutrition, 10(suppl_1), S49-S66.

Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109(1):119-121.

Sanders, M. E., Benson, A., Lebeer, S., Merenstein, D. J., & Klaenhammer, T. R. (2018). Shared mechanisms among probiotic taxa: implications for general probiotic claims. Current Opinion in Biotechnology, 49, 207-216.

Silva CCG, Silva SPM, Ribeiro SC. Application of Bacteriocins and Protective Cultures in Dairy Food Preservation. Front Microbiol. 2018;9:594. Published 2018 Apr 9.

Simon M, Pizzorno J, Katzinger J. Modifiable Risk Factors for SARS-CoV-2. Integr Med (Encinitas). 2021;20(5):8-14.

Sindhu KN, Sowmyanarayanan TV, Paul A, et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2014;58(8):1107-1115.

Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019). The pros, cons, and many unknowns of probiotics. Nature Medicine, 25(5), 716-729.

Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007). The human microbiome project. Nature, 449(7164), 804-810.

Turner et al., (2017) ‘Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection – a randomised controlled trial’ Beneficial Microbes, 8(2): 207-215.

Wang B, Hylwka T, Smieja M, Surrette M, Bowdish DME, Loeb M. Probiotics to Prevent Respiratory Infections in Nursing Homes: A Pilot Randomized Controlled Trial. J Am Geriatr Soc. 2018;66(7):1346-1352.

West NP et al., (2014), ‘Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy, physically active individuals’, Clinical Nutrition, 33(4):581-7.

Zocco, M A et al. “Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.” Alimentary pharmacology & therapeutics vol. 23,11 (2006): 1567-74.